Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pediatric hematologist oncologist

Similar presentations


Presentation on theme: "Pediatric hematologist oncologist"— Presentation transcript:

1 Pediatric hematologist oncologist
Dr Babak Abdolkarimi Pediatric hematologist oncologist 2و3 اسفند96-هرمزگان-قشم

2 Introduction: What drugs are needed, to treat the vast majority of SCD patients can be taken orally? The development of Hydroxyurea has been a major advance in the treatment of sickle cell disease, but is only partially effective in preventing vaso-occlusive crises.

3 Approach ameliorate the sequelae of HbS polymerization:
1. genetic approaches 2.non-genetic approaches

4

5 Etiology of VOC: 1.adhesion(phosphatidylserine exposure, Oxidative damage dyselasticity, Abnormal intracellular signaling) 2.inflammation(hypoxia/reperfusion,Platelet activation) 3. coagulation(Platelet activation, phosphatidylserine exposure 4.HbS polymerization(dehydration) 5. NO scavenging(HbS polymerization)

6 approaches to inhibiting HbS polymerization
1. Block intermolecular contacts in the sickle fiber 2. Induce HbF synthesis 3. Increase oxygen affinity 4. Reduce concentration of 2,3-DPG 5. Reduce intracellular Hb concentration.

7 Drug clasifications: 1. Anti-polymerization drugs(Niprisan,
SCD-101, GBT440, Aes-103) 2. adhesion cell blocker: a.Heparines(Sevuparin,LMWH,Dalteparin,UFH) b. P,E -selectin blocker(Rivipansel,selG1 c. signaling adhesion blocker(propranolol) d. Nonspecific inhibitors of adhesion(Poloxamer 188/surfactant,IVIg ,Simvastatin)

8 3. Anti-inflammatory drugs(Regadenoson, NKTT120,Montelukast,Ziluton)
4. HbF Inducer(Hydroxyurea, Tetrahydrouridine, Decitabine, HQK-1001, Pomalidomide) 5. Hemoglobin-modifying and anti-sickling agents( SCD-101, Sanguinate, Senicapoc, Aes-103, SCD-101, MP4CO) 6. Anticoagulants and antiplatelet agents(Abciximab, Dipyridamole/Magnesium, Eptifibatide, Prasugrel, Ticagrelor,ASA,Warfarin,Rivaroxaban,Apixaban)

9 Endari The mechanism of action of the amino acid
L-glutamine in treating sickle cell disease (SCD) is not fully understood but it seems inhibit Oxidative stress(chronic hemolysis & vaso-occlusive events). Pyridine nucleotides and NADH, preventing oxidative damage in RBCs by reducing glutathione.

10 Take home message: Available & safe drugs in IRAN: 1.Montelukast
2.Propranolol 3.ASA 4.IVIg 5.Simvastatin 6. Dipyridamole/Magnesium 7. Aspirin 8.Rivaroxaban


Download ppt "Pediatric hematologist oncologist"

Similar presentations


Ads by Google